Anders Björklund

Wallenberg Wood Science Center — Sweden

Neuroscience · Life Sciences

159h-index82.1kcitations882works8.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nerve injury and regeneration(266), Neurogenesis and neuroplasticity mechanisms(209), Neuroscience and Neuropharmacology Research(152), Parkinson's Disease Mechanisms and Treatments(119), Neurological disorders and treatments(111)

Publications879 total

STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease
BMJ Open·2025Open Access
STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease
Apollo (University of Cambridge)·2025
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson’s disease
Nature Biotechnology·2025· 9 citedOpen Access
TARGET-seq: Linking single-cell transcriptomics of human dopaminergic neurons with their target specificity
Proceedings of the National Academy of Sciences·2024· 16 citedOpen Access
The history and status of dopamine cell therapies for Parkinson's disease
BioEssays·2024· 11 citedOpen Access
The AAV-α-Synuclein Model of Parkinson’s Disease: An Update
Journal of Parkinson s Disease·2024· 18 citedOpen Access
Intergenerational inequalities across different outcomes: Comments from an economist
Edward Elgar Publishing eBooks·2024
The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson’s disease
Brain·2024· 17 citedOpen Access
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD
Cell stem cell·2023· 120 citedOpen Access
Introduction
Elsevier eBooks·2023
Sagittal sections
Elsevier eBooks·2023
Horizontal sections
Elsevier eBooks·2023
Restorative cell and gene therapies for Parkinson's disease
Handbook of clinical neurology·2023· 16 cited
Coronal sections
Elsevier eBooks·2023
A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System
Journal of Parkinson s Disease·2022· 21 citedOpen Access
In vivo conversion of dopamine neurons in mouse models of Parkinson’s disease — a future approach for regenerative therapy?
Current Opinion in Genetics & Development·2021· 9 cited
Facts and Myths in the Popular Debate about Inequality in Sweden
RePEc: Research Papers in Economics·2021· 4 cited
Dopamine Cell Therapy: From Cell Replacement to Circuitry Repair
Journal of Parkinson s Disease·2021· 26 citedOpen Access
Stem Cell-Derived Dopamine Neurons: Will They Replace DBS as the Leading Neurosurgical Treatment for Parkinson's Disease?
Apollo (University of Cambridge)·2021· 4 citedOpen Access
Sverige är inte ett land med stor och växande ojämlikhet
2021· 1 cited
page 1 of 44Next →

Frequent Co-authors

Olle Lindvall(13), Stephen B. Dunnett(9), Patrik Brundin(8), Deniz Kirik(8), Ulf Stenevi(8), Stig Rehncrona(6), Håkan Widner(6), Carl Rosenblad(6), Ronald J. Mandel(5), Peter Hagell(4), David J. Brooks(4), Niall Quinn(3), Klas Wictorin(3), Fred H. Gage(3), Bengt Mattsson(3), Johan Jakobsson(3), Malin Parmar(3), Corinna Bürger(3), Cecilia Lundberg(3), Nicholas Muzyczka(3)